In conclusion, this study provides compelling evidence that the Msi1-mTOR signaling pathway plays a critical role in the pathogenesis of EMPD and that targeting mTOR signaling may offer a novel therapeutic approach for treating this disease. Here, MTOR is linked to extramammary Paget disease.